A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

NCT06033950 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

2600

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Finerenone
DRUG: Placebo

Sponsor

Colorado Prevention Center

Collaborators

[object Object]
[object Object]